参考文献 References
[1] MORISHIMA-KAWASHIMA M, HARA Y.Alzheimer'sdisease: beta-amyloid protein and tau [J]. J Neurosci Res, 2002, 70(3): 392-401.
[2] SOLITO E, SASTRE M. Microglia function in Alzheimer's disease [J]. Frontiers in Pharmacology, 2012, 3.
[3] YAO K, ZU H B. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease [J]. Inflammopharmacology, 2020, 28(1): 95-110.
[4] COLONNA M, BUTOVSKY O.Microglia Function in the Central Nervous System During Health and Neurodegeneration [J]. Annu Rev Immunol, 2017, 35: 441-68.
[5] WAKE H, MOORHOUSE A J, JINNO S, et al. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals [J]. J Neurosci, 2009, 29(13): 3974-80.
[6] MARTINEZ F O, GORDON S. The M1 and M2 paradigm of macrophage activation: time for reassessment [J]. F1000Prime Rep, 2014, 6: 13.
[7] TANG Y, LE W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases [J]. Mol Neurobiol, 2016, 53(2): 1181-94.
[8] SPANIC E, LANGER HORVAT L, HOF P R, et al. Role of Microglial Cells in Alzheimer's Disease Tau Propagation [J]. Front Aging Neurosci, 2019, 11: 271.
[9] GOLD M, EL KHOURY J. β-amyloid, microglia, and the inflammasome in Alzheimer’s disease [J]. Seminars in Immunopathology, 2015, 37(6): 607-11.
[10] SCHL ACHETZKI J C, HULL M. Microglial activation in Alzheimer's disease [J]. Curr Alzheimer Res, 2009, 6(6): 554-63.
[11] WU X, KOSARAJU J, TAM K Y. Anti-neuroinflamm-atory effects of SLOH in Abeta-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3beta [J]. Neurosci Lett, 2018, 687: 207-15.
[12] FRAME S, COHEN P. GSK3 takes centre stage more than 20 years after its discovery [J]. Biochem J, 2001, 359: 1-16.
[13] SAYAS C L, AVILA J. GSK-3 and Tau: A Key Duet in Alzheimer's Disease [J]. Cells, 2021, 10(4).
[14] FAN X H, ZHAO Z Y, WANG D M, et al. Glycogen synthase kinase-3 as a key regulator of cognitive function [J]. Acta Bioch Bioph Sin, 2020, 52(3): 219-30.
[15] TAN X, LIANG Z, LI Y, et al. Isoorientin, a GSK-3beta inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice [J]. Behav Brain Res, 2021, 398: 112968.
[16] XIAN Y F, QU C, LIU Y, et al. Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease [J]. Oxid Med Cell Longev, 2020, 2020: 5920476.
[17] WANG H, SUI H J, ZHENG Y, et al.Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3 beta pathway [J]. Nanoscale, 2019, 11(15): 7481-96.
[18] LANDRETH G, JIANG Q G, MANDREKAR S, et al. PPAR gamma agonists as therapeutics for the treatment of Alzheimer's disease [J]. Neurotherapeutics, 2008, 5(3): 481-9.
[19] ESCRIBANO L, SIMON A M, GIMENO E, et al. Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology [J]. Neuropsychopharmacology, 2010, 35(7): 1593-604.
[20] CHENG Y J, DONG Z, LIU S. beta-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPAR gamma Pathway [J]. Pharmacology, 2014, 94(1-2): 1-12.
[21] WANG D, DONG X, WANG C. Honokiol Ameliorates Amyloidosis and Neuroinflammation and Improves Cognitive Impairment in Alzheimer's Disease Transgenic Mice [J]. J Pharmacol Exp Ther, 2018, 366(3): 470-8.
[22] KIM E K, CHOI E J. Pathological roles of MAPK signaling pathways in human diseases [J]. Biochim Biophys Acta, 2010, 1802(4): 396-405.
[23] JU Y J, KIM N, GEE M S, et al. Glibenclamide modulates microglial function and attenuates Abeta deposition in 5XFAD mice [J]. Eur J Pharmacol, 2020, 884: 173416.
[24] LIU J M, LI H J, GONG T Y, et al. Anti-neuroinflammatory Effect of Short-Chain Fatty Acid Acetate against Alzheimer's Disease via Upregulating GPR41 and Inhibiting ERK/JNK/NF-kappa B [J]. J Agr Food Chem, 2020, 68(27): 7152-61.
[25] HONG Z Y, SHI X R, ZHU K, et al. SCM-198 inhibits microglial overactivation and attenuates Abeta(1-40)-induced cognitive impairments in rats via JNK and NF-small ka, CyrillicB pathways [J]. J Neuroinflammation, 2014, 11: 147.
[26] GUO M F, ZHANG H Y, LI Y H, et al. Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4/Myd88/NF-kappaB pathway [J]. J Neuroimmunol, 2020, 346: 577284.
[27] YU J Z, LI Y H, LIU C Y, et al. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice [J]. CNS Neurol Disord Drug Targets, 2017, 16(2): 199-209.
[28] ZHANG Z Y, SCHLUESENER H J. Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model [J]. J Neuropathol Exp Neurol, 2013, 72(3): 178-85.
[29] GUO H B, CHENG Y F, WU J G, et al. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation [J]. Neuroscience, 2015, 290: 530-42.